Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan E Pomeroy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biotechnology Advances|February 23, 2019
Biomaterializing the promise of cardiac tissue engineeringJordan E Pomeroy, Abbigail Helfer, Nenad Bursac
Cell Stem Cell|June 24, 2010
Current technology for the derivation of pluripotent stem cell lines from human embryosKouichi Hasegawa, Jordan E Pomeroy, Martin F Pera
Theranostics|September 16, 2017
Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem CellsJordan E Pomeroy, Hung X Nguyen, Brenton D Hoffman, et al.
Journal of the American College of Cardiology|January 15, 2025
Responder Analyses Can Be MisleadingMary Ross Southworth, Mitchell A Psotka, Jordan E Pomeroy, et al.
Stem Cells (Dayton, Ohio)|June 24, 2010
Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusionKouichi Hasegawa, Peilin Zhang, Zong Wei, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptorsRobert E Petroski, Jordan E Pomeroy, Ronnie Das, et al.
Stem Cells Translational Medicine|May 11, 2016
Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human FibroblastsJordan E Pomeroy, Shelley R Hough, Kathryn C Davidson, et al.
JACC. Heart Failure|June 26, 2026
Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure CollaboratoryVanessa Blumer, Janet T Wittes, Jordan E Pomeroy, et al.
The European Journal of Neuroscience|July 20, 2005
Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampusJulie V Selkirk, Lisa M Nottebaum, Alicia M Vana, et al.
Molecular and Cellular Endocrinology|September 22, 2006
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 functionDavid A Schwarz, Molly M Allen, Robert E Petroski, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biotechnology Advances|February 23, 2019
Biomaterializing the promise of cardiac tissue engineeringJordan E Pomeroy, Abbigail Helfer, Nenad Bursac
Cell Stem Cell|June 24, 2010
Current technology for the derivation of pluripotent stem cell lines from human embryosKouichi Hasegawa, Jordan E Pomeroy, Martin F Pera
Theranostics|September 16, 2017
Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem CellsJordan E Pomeroy, Hung X Nguyen, Brenton D Hoffman, et al.
Journal of the American College of Cardiology|January 15, 2025
Responder Analyses Can Be MisleadingMary Ross Southworth, Mitchell A Psotka, Jordan E Pomeroy, et al.
Stem Cells (Dayton, Ohio)|June 24, 2010
Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusionKouichi Hasegawa, Peilin Zhang, Zong Wei, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2006
Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptorsRobert E Petroski, Jordan E Pomeroy, Ronnie Das, et al.
Stem Cells Translational Medicine|May 11, 2016
Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human FibroblastsJordan E Pomeroy, Shelley R Hough, Kathryn C Davidson, et al.
JACC. Heart Failure|June 26, 2026
Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure CollaboratoryVanessa Blumer, Janet T Wittes, Jordan E Pomeroy, et al.
The European Journal of Neuroscience|July 20, 2005
Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampusJulie V Selkirk, Lisa M Nottebaum, Alicia M Vana, et al.
Molecular and Cellular Endocrinology|September 22, 2006
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 functionDavid A Schwarz, Molly M Allen, Robert E Petroski, et al.
Pageof 1